ARCH Venture Partners X, LLC - 10%+ Owner at Neumora Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
NMRA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by ARCH Venture Partners X, LLC since 11/5/2023

Holdings reported by ARCH Venture Partners X, LLC for Neumora Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 12.2M $146M $11.98 Dec 8, 2023 By ARCH Venture Fund X, L.P.
Common Stock 11.9M $142M $11.98 Dec 8, 2023 By ARCH Venture Fund X Overage, L.P.
Common Stock 4.13M $49.5M $11.98 Dec 8, 2023 By ARCH Venture Fund XII, L.P.
Common Stock 2.32M $27.8M $11.98 Dec 8, 2023 By ARCH Venture Fund VIII Overage, L.P.
Common Stock 1.39M $16.6M $11.98 Dec 8, 2023 By ARCH Venture Fund VII, L.P.
Series A-1 Preferred Stock 0 Sep 19, 2023 By ARCH Venture Fund VIII Overage, L.P. Common Stock
Series A-1 Preferred Stock 0 Sep 19, 2023 By ARCH Venture Fund VII, L.P. Common Stock
Series A-2 Preferred Stock 0 Sep 19, 2023 By ARCH Venture Fund X, L.P. Common Stock
Series A-2 Preferred Stock 0 Sep 19, 2023 By ARCH Venture Fund X Overage, L.P. Common Stock
Series B Preferred Stock 0 Sep 19, 2023 By ARCH Venture Fund XII, L.P. Common Stock

Transactions reported by ARCH Venture Partners X, LLC for Neumora Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.